WallStSmart
NKTR

Nektar Therapeutics

NASDAQ: NKTR · HEALTHCARE · BIOTECHNOLOGY

$83.20
-0.73% today

Updated 2026-04-29

Market cap
$2.76B
P/E ratio
P/S ratio
50.03x
EPS (TTM)
$-9.73
Dividend yield
52W range
$8 – $109
Volume
1.1M

Nektar Therapeutics (NKTR) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Revenue$217.72M$273.03M$90.19M$71.93M$159.04M$71.48M$81.19M$148.92M$200.71M$230.78M$165.44M$307.71M$1.19B$114.62M$152.91M$101.91M$92.06M$90.12M$98.43M$55.23M
Revenue growth (YoY)+25.4%-67.0%-20.2%+121.1%-55.1%+13.6%+83.4%+34.8%+15.0%-28.3%+86.0%+287.8%-90.4%+33.4%-33.4%-9.7%-2.1%+9.2%-43.9%
Cost of revenue$118.09M$147.52M$35.04M$30.95M$25.67M$21.89M$30.43M$38.51M$28.53M$34.10M$30.21M$30.55M$24.41M$21.37M$19.48M$24.90M$21.64M$36.64M$30.69M$0.00
Gross profit$99.63M$125.51M$55.15M$40.98M$133.37M$49.59M$50.76M$110.41M$172.17M$196.68M$135.22M$277.16M$1.17B$93.24M$133.44M$77.01M$70.42M$53.48M$67.74M$55.23M
Gross margin45.8%46.0%61.1%57.0%83.9%69.4%62.5%74.1%85.8%85.2%81.7%90.1%98.0%81.4%87.3%75.6%76.5%59.3%68.8%100.0%
R&D$149.38M$153.57M$154.42M$95.11M$108.06M$126.77M$148.68M$190.01M$147.73M$182.79M$203.80M$268.46M$399.54M$434.57M$408.68M$400.27M$218.32M$114.16M$120.91M$117.33M
SG&A$78.32M$56.34M$51.50M$41.01M$40.99M$46.76M$41.61M$40.53M$40.92M$43.27M$44.27M$52.36M$81.44M$98.71M$104.68M$122.84M$92.33M$77.42M$76.75M$68.67M
Operating income$-159.23M$-36.15M$-82.65M$-95.13M$-28.25M$-123.94M$-141.20M$-120.13M$-16.48M$-29.37M$-112.86M$-59.64M$687.93M$-440.04M$-379.92M$-446.10M$-240.24M$-137.43M$-105.20M$-130.77M
Operating margin-73.1%-13.2%-91.6%-132.3%-17.8%-173.4%-173.9%-80.7%-8.2%-12.7%-68.2%-19.4%57.6%-383.9%-248.5%-437.8%-261.0%-152.5%-106.9%-236.8%
EBITDA$-125.72M$-7.12M$2.54M$-75.72M$-9.33M$-107.79M$-124.10M$-106.01M$-2.74M$-29.37M$-97.27M$-42.52M$734.30M$-382.70M$-394.33M$-461.82M$-323.87M$-243.11M$-86.70M$-129.74M
EBITDA margin-57.7%-2.6%2.8%-105.3%-5.9%-150.8%-152.9%-71.2%-1.4%-12.7%-58.8%-13.8%61.5%-333.9%-257.9%-453.2%-351.8%-269.8%-88.1%-234.9%
EBIT$-158.36M$-35.27M$-19.95M$-90.60M$-25.88M$-122.74M$-138.61M$-120.28M$-15.67M$-42.23M$-110.47M$-55.12M$725.50M$-393.70M$-406.83M$-475.97M$-336.07M$-250.92M$-91.09M$-130.77M
Interest expense$20.26M$18.64M$15.19M$12.18M$11.17M$10.22M$33.55M$40.76M$38.76M$38.90M$42.18M$40.95M$42.78M$46.35M$37.12M$47.31M$28.91M$25.33M$28.11M$26.18M
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-154.76M$-32.76M$-34.34M$-102.52M$-37.94M$-133.98M$-171.85M$-162.01M$-53.92M$-81.18M$-153.52M$-96.69M$681.31M$-440.67M$-444.44M$-523.84M$-368.20M$-276.06M$-118.96M$-164.08M
Net income growth (YoY)+78.8%-4.8%-198.6%+63.0%-253.1%-28.3%+5.7%+66.7%-50.6%-89.1%+37.0%+804.6%-164.7%-0.9%-17.9%+29.7%+25.0%+56.9%-37.9%
Profit margin-71.1%-12.0%-38.1%-142.5%-23.9%-187.4%-211.7%-108.8%-26.9%-35.2%-92.8%-31.4%57.1%-384.5%-290.6%-514.0%-400.0%-306.3%-120.9%-297.1%